BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bassegoda O, Huelin P, Ariza X, Solé C, Juanola A, Gratacós-Ginès J, Carol M, Graupera I, Pose E, Napoleone L, Albertos S, de Prada G, Cervera M, Fernández J, Fabrellas N, Poch E, Solà E, Ginès P. Development of chronic kidney disease after acute kidney injury in patients with cirrhosis is common and impairs clinical outcomes. J Hepatol 2020;72:1132-9. [PMID: 31953138 DOI: 10.1016/j.jhep.2019.12.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Chou YT, Liu TT, Yang UC, Huang CC, Liu CW, Huang SF, Li TH, Liu HM, Lin MW, Yang YY, Lee TY, Huang YH, Hou MC, Lin HC. Intestinal SIRT1 Deficiency-Related Intestinal Inflammation and Dysbiosis Aggravate TNFα-Mediated Renal Dysfunction in Cirrhotic Ascitic Mice. Int J Mol Sci 2021;22:1233. [PMID: 33513830 DOI: 10.3390/ijms22031233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Singh I, De A, Singh V. Transition of AKI to CKD in cirrhosis - effect of baseline eGFR and unanswered questions. J Hepatol 2020;73:737-8. [PMID: 32540208 DOI: 10.1016/j.jhep.2020.03.022] [Reference Citation Analysis]
3 Cheng JH, Yip CW, Jiang YK, Zhou LH, Que CX, Luo Y, Wang X, Zhao HZ, Zhu LP. Clinical Predictors Impacting Cryptococcal Dissemination and Poor Outcome in Patients With Cirrhosis. Open Forum Infect Dis 2021;8:ofab296. [PMID: 34250196 DOI: 10.1093/ofid/ofab296] [Reference Citation Analysis]
4 Khoshdel-Rad N, Zahmatkesh E, Shpichka A, Timashev P, Vosough M. Outbreak of chronic renal failure: will this be a delayed heritage of COVID-19? J Nephrol 2021;34:3-5. [PMID: 32876938 DOI: 10.1007/s40620-020-00851-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Piano S, Gambino C, Vettore E, Calvino V, Tonon M, Boccagni P, Gringeri E, Germani G, Burra P, Cillo U, Angeli P. Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome. Hepatology 2021;73:1909-19. [PMID: 32870499 DOI: 10.1002/hep.31529] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
6 Desai AP, Knapp SM, Orman ES, Ghabril MS, Nephew LD, Anderson M, Ginès P, Chalasani NP, Patidar KR. Changing epidemiology and outcomes of acute kidney injury in hospitalized patients with cirrhosis - a US population-based study. J Hepatol 2020;73:1092-9. [PMID: 32387698 DOI: 10.1016/j.jhep.2020.04.043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
7 Pacheco MP, Carneiro-D'Albuquerque LA, Mazo DF. Current aspects of renal dysfunction after liver transplantation. World J Hepatol 2022; 14(1): 45-61 [DOI: 10.4254/wjh.v14.i1.45] [Reference Citation Analysis]
8 Yu Y, Xie S, Wang K, Zhang F, Jiang C, Qiu C, Zhu J, Shen W. Perfusion Analysis of Kidney Injury in Rats With Cirrhosis Induced by Common Bile Duct Ligation Using Arterial Spin Labeling MRI. J Magn Reson Imaging 2021. [PMID: 34499757 DOI: 10.1002/jmri.27917] [Reference Citation Analysis]
9 Kumar R, Priyadarshi RN, Anand U. Chronic renal dysfunction in cirrhosis: A new frontier in hepatology. World J Gastroenterol 2021; 27(11): 990-1005 [PMID: 33776368 DOI: 10.3748/wjg.v27.i11.990] [Reference Citation Analysis]
10 Maiwall R, Pasupuleti SSR, Jain P, Sarin SK. Degree of Portal and Systemic Hemodynamic Alterations Predict Recurrent AKI and Chronic Kidney Disease in Patients With Cirrhosis. Hepatol Commun 2021;5:293-308. [PMID: 33553976 DOI: 10.1002/hep4.1607] [Reference Citation Analysis]
11 Patidar KR, Naved MA, Grama A, Adibuzzaman M, Ali AA, Slaven JE, Desai AP, Ghabril MS, Nephew L, Chalasani N, Orman ES. Acute Kidney Disease is Common and Associated with Poor Outcomes in Patients with Cirrhosis and Acute Kidney Injury. J Hepatol 2022:S0168-8278(22)00115-5. [PMID: 35217065 DOI: 10.1016/j.jhep.2022.02.009] [Reference Citation Analysis]
12 Pyne JD, Brickman AM. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline. Neurodegener Dis 2021;21:1-23. [PMID: 34348321 DOI: 10.1159/000518581] [Reference Citation Analysis]
13 Tonon M, Rosi S, Gambino CG, Piano S, Calvino V, Romano A, Martini A, Pontisso P, Angeli P. Natural history of acute kidney disease in patients with cirrhosis. Journal of Hepatology 2021;74:578-83. [DOI: 10.1016/j.jhep.2020.08.037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
14 Duan Y, Li Z, Wang X, Cui L, Gao Z, Zhang H. Risk Factors and Prognosis of New-Onset Chronic Kidney Disease Following Orthotopic Liver Transplantation: A Retrospective Case-Control Study. Med Sci Monit 2021;27:e931834. [PMID: 34537807 DOI: 10.12659/MSM.931834] [Reference Citation Analysis]
15 Huang Y, Yang L. Mesenchymal stem cells and extracellular vesicles in therapy against kidney diseases. Stem Cell Res Ther 2021;12:219. [PMID: 33789750 DOI: 10.1186/s13287-021-02289-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Niewiński G, Smyk W, Graczyńska A, Kostrzewa K, Raszeja-Wyszomirska J, Ołdakowska-Jedynak U, Małyszko J, Wójcicki M, Zieniewicz K. Kidney Function After Liver Transplantation in a Single Center. Ann Transplant 2021;26:e926928. [PMID: 33619240 DOI: 10.12659/AOT.926928] [Reference Citation Analysis]
17 Juanola A, Solé C, Toapanta D, Ginès P, Solà E. Monitoring Renal Function and Therapy of Hepatorenal Syndrome Patients with Cirrhosis. Clin Liver Dis 2021;25:441-60. [PMID: 33838860 DOI: 10.1016/j.cld.2021.01.011] [Reference Citation Analysis]
18 Cullaro G, Verna EC, Duarte-Rojo A, Kappus MR, Ganger DR, Rahimi RS, Boyarsky B, Segev DL, McAdams-DeMarco M, Ladner DP, Volk ML, Hsu CY, Lai JC. Frailty and the Risk of Acute Kidney Injury Among Patients With Cirrhosis. Hepatol Commun 2021. [PMID: 34676697 DOI: 10.1002/hep4.1840] [Reference Citation Analysis]
19 Francoz C. Acute kidney injury in cirrhosis: An immediate threat but also a ticking time bomb. J Hepatol. 2020;72:1043-1045. [PMID: 32197803 DOI: 10.1016/j.jhep.2020.02.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Hiramine Y, Uto H, Mawatari S, Kanmura S, Imamura Y, Hiwaki T, Saishoji A, Oku M, Tokushige K, Maenohara S, Ido A. Impact of acute kidney injury on prognosis and the effect of tolvaptan in patients with hepatic ascites. J Gastroenterol 2021;56:54-66. [PMID: 32959093 DOI: 10.1007/s00535-020-01727-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Ma AT, Juanola A, Solà E. Assessment of kidney function in cirrhosis: Are we moving closer to accurate estimation of glomerular filtration rate? Liver Int 2022;42:957-9. [PMID: 35447007 DOI: 10.1111/liv.15238] [Reference Citation Analysis]